Group One Trading’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Group One Trading's AVIR Position: Q3 2026 in Review
Group One Trading increased its Atea Pharmaceuticals (AVIR) stake by 4,570% in Q3 2026, buying an estimated $32.7K and bringing the position to 6,538 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5517.
Group One Trading first reported a position in AVIR in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.32M in Q4 2021. 89 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Group One Trading held 6,538 shares of Atea Pharmaceuticals worth $34.1K as of Q3 2026.
- Group One Trading bought 6,398 Atea Pharmaceuticals shares in Q3 2026, an estimated $32.7K.
- Atea Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5517 holding.
- Group One Trading first reported a position in Atea Pharmaceuticals in Q3 2021 and has held it in 14 quarters since.
- Group One Trading's Atea Pharmaceuticals position peaked at $1.32M in Q4 2021.
- 89 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.